These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33101364)

  • 1. Identification of a Novel Signature and Construction of a Nomogram Predicting Overall Survival in Clear Cell Renal Cell Carcinoma.
    Wu X; Zhao Z; Khan A; Cai C; Lv D; Gu D; Liu Y
    Front Genet; 2020; 11():1017. PubMed ID: 33101364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma.
    Liao Z; Yao H; Wei J; Feng Z; Chen W; Luo J; Chen X
    Transl Androl Urol; 2021 Apr; 10(4):1607-1619. PubMed ID: 33968649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
    Jiang W; Guo Q; Wang C; Zhu Y
    Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.
    Liu C; Zhang X; Hu C; Liang X; Cao X; Wang D
    Front Genet; 2022; 13():877656. PubMed ID: 35774505
    [No Abstract]   [Full Text] [Related]  

  • 5. A Bioinformatic Analysis of Immune-Related Prognostic Genes in Clear Cell Renal Cell Carcinoma Based on TCGA and GEO Databases.
    Li J; Cao J; Li P; Deng R; Yao Z; Ying L; Tian J
    Int J Gen Med; 2022; 15():325-342. PubMed ID: 35035230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma.
    Zheng H; Liu H; Lu Y; Li H
    Front Surg; 2021; 8():717084. PubMed ID: 34631779
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.
    Yuan B; Li F; Li Y; Chen Y
    Cancer Manag Res; 2020; 12():4017-4027. PubMed ID: 33116819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway.
    Di S; Gong M; Lv J; Yang Q; Sun Y; Tian Y; Qian C; Chen W; Zhou W; Dong K; Shi X; Wang Y; Wang H; Chu J; Gan S; Pan X; Cui X
    Cancer Cell Int; 2023 Aug; 23(1):186. PubMed ID: 37649034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
    Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
    Front Genet; 2020; 11():810. PubMed ID: 33014010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of LIF predicts a poor prognosis and promotes cell migration and invasion of clear cell renal cell carcinoma.
    Zhong W; Liu H; Li F; Lin Y; Ye Y; Xu L; Li S; Chen H; Li C; Lin Y; Zhuang W; Lin Y; Wang Q
    Front Oncol; 2022; 12():934128. PubMed ID: 35992780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma.
    Lv D; Wu X; Wang M; Chen W; Yang S; Liu Y; Zeng G; Gu D
    Front Cell Dev Biol; 2021; 9():621618. PubMed ID: 33796525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma.
    Wu J; Jin S; Gu W; Wan F; Zhang H; Shi G; Qu Y; Ye D
    Front Oncol; 2019; 9():152. PubMed ID: 30941304
    [No Abstract]   [Full Text] [Related]  

  • 18. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
    Front Oncol; 2020; 10():788. PubMed ID: 32528886
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
    Zhang L; Su Z; Hong F; Wang L
    Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
    Zheng D; Zhang Y; Xia Y; Cheng F
    Front Oncol; 2022; 12():840410. PubMed ID: 35371994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.